FDA — authorised 6 January 1960
- Marketing authorisation holder: EASTMAN KODAK
- Status: approved
🇺🇸 Levonordefrin in United States
FDA authorised Levonordefrin on 6 January 1960
Marketing authorisations
FDA — authorised 6 February 1976
- Application: ANDA084697
- Marketing authorisation holder: SEPTODONT
- Local brand name: ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 15 April 1976
- Application: ANDA085010
- Marketing authorisation holder: SOLVAY
- Local brand name: ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Levonordefrin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Levonordefrin approved in United States?
Yes. FDA authorised it on 6 January 1960; FDA authorised it on 6 February 1976; FDA authorised it on 15 April 1976.
Who is the marketing authorisation holder for Levonordefrin in United States?
EASTMAN KODAK holds the US marketing authorisation.